Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen D Silberstein

Showing results (31-40 of 251) with videos related to

Pageof 26
Sort By:
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Analyses of cost-effectiveness of migraine therapies should consider multiple measuresStephen D Silberstein
Lancet (London, England)|April 9, 2004
MigraineStephen D Silberstein
Neurologic Clinics|April 6, 2004
Headaches due to nasal and paranasal sinus diseaseStephen D Silberstein
Headache|April 19, 2005
Topiramate in migraine preventionStephen D Silberstein
Headache|May 15, 2002
Control of topiramate-induced paresthesias with supplemental potassiumStephen D Silberstein
Headache|May 25, 2002
Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introductionStephen D Silberstein
Headache|May 10, 2017
NeuropeptidesStephen D Silberstein
Nature Clinical Practice. Neurology|March 16, 2007
Diagnostic testing in episodic migraine: should it include magnetic resonance venography?Stephen D Silberstein
Aesthetic Surgery Journal|April 1, 2009
Clinical results of botulinum toxin type a treatment of migraine headacheStephen D Silberstein
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2010
Association between restless legs syndrome and migraineStephen D Silberstein
Pageof 26

Showing results (31-40 of 251) with videos related to

Sort By:
Pageof 26
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Analyses of cost-effectiveness of migraine therapies should consider multiple measuresStephen D Silberstein
Lancet (London, England)|April 9, 2004
MigraineStephen D Silberstein
Neurologic Clinics|April 6, 2004
Headaches due to nasal and paranasal sinus diseaseStephen D Silberstein
Headache|April 19, 2005
Topiramate in migraine preventionStephen D Silberstein
Headache|May 15, 2002
Control of topiramate-induced paresthesias with supplemental potassiumStephen D Silberstein
Headache|May 25, 2002
Pharmacological profile and clinical characteristics of frovatriptan in the acute treatment of migraine: introductionStephen D Silberstein
Headache|May 10, 2017
NeuropeptidesStephen D Silberstein
Nature Clinical Practice. Neurology|March 16, 2007
Diagnostic testing in episodic migraine: should it include magnetic resonance venography?Stephen D Silberstein
Aesthetic Surgery Journal|April 1, 2009
Clinical results of botulinum toxin type a treatment of migraine headacheStephen D Silberstein
Journal of Neurology, Neurosurgery, and Psychiatry|May 13, 2010
Association between restless legs syndrome and migraineStephen D Silberstein
Pageof 26